Warning letter
Allegis Pharmaceuticals, LLC [ARCHIVED]: warning letter of Nov 13, 2009
FDA warning letter 71143 · New Orleans District Office
Key facts
| Reference number | 71143 |
|---|---|
| Company | Allegis Pharmaceuticals, LLC [ARCHIVED] |
| Subject | Lacks Approved New Drug Application/Adulterated |
| Issue date | Nov 13, 2009 |
| Posted date | Nov 13, 2009 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 201.5, 201.115 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: